Skip to main content
. 2020 Nov 6;69(2):500–505. doi: 10.1111/jgs.16927

Table 1.

Preintervention Baseline Characteristics of Patients

Characteristic Patients surviving 1‐year follow up (n = 278) Patients who died before 1‐year follow up (n = 52)
General characteristics
Age, years, median (IQR) 83.4 (5.5) 84.2 (6.4)
Female gender, n (%) 157 (56.5) 29 (55.8)
Body mass index, kg/m2, median (IQR) 25.3 (5.4) 24.0 (5.1)
Number of comorbidities a , median (IQR) 3.0 (2.0) 4.0 (2.0) b
Cardiac parameters
Dyspnea NYHA class III or IV, n (%) 182 (65.5) 37 (71.2)
Angina CCS score III or IV, n (%) 38 (13.7) 5 (9.6)
Left ventricular ejection fraction, %, median (IQR) 60.0 (20.0) 50.0 (25.0) b
Mean gradient aortic valve, mmHg, median (IQR) 42.0 (21.0) 38.0 (24.5)
Aortic valve area, cm2, median (IQR) 0.6 (0.3) 0.6 (0.3)
Comprehensive geriatric assessment parameters
Cognitive impairment (MMSE <27 points), n (%) 85 (30.6) 25 (48.1) b
Mobility impairment (TUG ≥20 seconds), n (%) 81 (29.1) 32 (61.5) b
At risk of malnutrition (MNA <12 points), n (%) 120 (43.2) 34 (65.4) b
Basic ADL ≥1 limitation, n (%) 62 (22.3) 20 (38.5)b
Instrumental ADL ≥1 limitation, n (%) 181 (65.1) 35 (67.1)
Preclinical mobility disability c , n (%) 170 (61.1) 35 (67.1)
Risk scores
Frailty status: nonfrail (frailty index <3), n (%) 146 (52.5) 15 (28.8) b
Frailty status: frail (frailty index 3 or 4), n (%) 98 (35.3) 18 (34.6)
Frailty status: very frail (frailty index ≥5), n (%) 34 (12.2) 19 (36.5) b
Logistic EuroSCORE, median (IQR) 18.1 (15.7) 28.1 (21.4) b
STS score, median (IQR) 5.6 (3.8) 7.3 (5.7) b

Abbreviations: ADL, activities of daily living; CCS, Canadian Cardiovascular Society; IQR, interquartile range; MMSE, Mini Mental State Exam; MNA, Mini Nutritional Assessment; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons; TAVI, transcatheter aortic valve implantation; TUG, timed get up and go test.

a

Extracted from clinical records, based on a list of 10 chronic conditions. 10

b

Significant group difference (P < .05) between surviving patients and patients who died based on chi‐squared test or Kruskal‐Wallis test.

c

Self‐reported decreased frequency of walking 200 m or of climbing stairs during the 6 months before baseline. 18